News
Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute
EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf released a letter to Aurora shareholders and scheduled a direct Q&A session with its CEO. Aurora responded to Curaleaf’s application ...
Definium Achieves Second Positive Phase 3 for GAD
NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and in major depressive disorder (MDD). The trial evaluated a single dose of DT120, an orally disintegrating tablet formulation of lysergide ...
High Tide Reports Q3 2026 Financial Results
CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit came in at $52.7 million, up 32% year-over-year, with gross margin holding steady at 27%. Adjusted EBITDA reached $16.2 million, ...
Curaleaf Escalates Aurora Fight, Asks Alberta Regulator to Freeze Share Sales
STAMFORD – Curaleaf Holdings Inc. submitted a formal application to the Alberta Securities Commission (ASC), seeking to halt Aurora Cannabis's at-the-market share issuance program while Curaleaf's offer to acquire all outstanding Aurora shares remains outstanding. The company has simultaneously requested an expedited hearing, as disclosed in the official company press release. The formal bid – ...
Dutch Cannabis Supply Pilot Delivers Lower Prices and a Fuller Shelf
AMSTERDAM – A report published by the Trimbos Institute, RAND Europe, and Breuer&Intraval compared ten municipalities where coffeeshops sell exclusively licensed-grown Сannabis against ten operating under the country's traditional tolerance policy. The program launched April 7, 2025. The first follow-up covers data through the first quarter of 2026. The sharpest early change showed up in ...
Cannara Secures Upgraded $80M Credit Line
MONTREAL – Cannara Biotech Inc. announced that its operating subsidiary has entered into an amended and restated syndicated credit agreement with Bank of Montreal (BMO) and The Toronto-Dominion Bank (TD), establishing $80 million in committed borrowing capacity, a $30 million increase from the approximately $50 million accessible before refinancing. The new structure splits the facility ...
Virginia Unveils Draft Rules for Adult-Use Cannabis Market
RICHMOND – The Virginia Cannabis Control Authority (CCA) released an 80-plus-page draft regulatory framework for the state's forthcoming adult-use market – the first detailed set of proposed rules since the General Assembly authorized commercial sales earlier this year. Licensed retailers are scheduled to open their doors on July 1, 2027. The document spans every stage ...
Metrc Rolls Out Compliance Events for New York Cannabis Operators
NEW YORK – Track-and-trace provider Metrc announced a pair of statewide User Exchange events in New York, one in New York City on September 14 and another in Syracuse on September 16, designed to help Cannabis licensees sharpen their compliance practices and extract greater operational value from the state's seed-to-sale tracking system. The events will ...
Eli Lilly Completes Acquisition of AtaiBeckley
INDIANAPOLIS – Eli Lilly & Co. has closed its acquisition of AtaiBeckley Inc., the New York-based biopharmaceutical company developing psychedelic-derived therapies for treatment-resistant mental health conditions. The transaction cleared its final U.S. regulatory checkpoint when the premerger antitrust review waiting period expired on August 28, completing the last material hurdle before formal close. Under the ...
Curaleaf Fires Back at Aurora Claims with Detailed Fact Sheet
STAMFORD – Curaleaf Holdings Inc. released a 14-point public fact sheet taking direct aim at what it described as misleading statements Aurora Cannabis Inc. has circulated in opposition to Curaleaf's unsolicited bid to acquire the company. The hostile takeover bid values Aurora at approximately US$272 million (C$374.8 million). Aurora's board unanimously rejected the proposal and ...
Cannaflex Opens European Export Route
RABAT – Moroccan operator Cannaflex has secured EU-GMP compliance verification for the commercial export of medical Cannabis starting materials to Switzerland and broader European markets, marking an operational milestone for the Kingdom's legal framework. Working in collaboration with Swiss-based Pharmaserv AG, the documented supply pathway links GACP-certified cultivation in Morocco's historic Rif region directly with ...
Opus Consulting Appointed Receiver for PharmaCann Maryland Assets
BALTIMORE – Business advisory firm Opus Consulting, acting through President Jacques Santucci, has been appointed court receiver for the Maryland assets of PharmaCann, initiating a court-approved structured bidding process to sell the company’s state-issued licenses and operational infrastructure. The receivership, ordered by the Circuit Court for Montgomery County, MD, follows an action initiated by Argent ...
Grown Rogue Launches Cultivation Ops in Minnesota
MEDFORD – Grown Rogue International Inc. officially began cultivation operations at its Fridley, Minnesota facility, nine months after first securing the location in December 2025. Phase I puts roughly 8,000 sq. feet of flowering canopy into production. The first indoor craft flower to come out of a purpose-built, multi-state-operator facility inside the state. The building ...
NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy
AUSTIN – A new study from The University of Texas MD Anderson Cancer Center suggests that psilocybin, the psychedelic compound found in certain mushrooms, could eventually help prevent one of chemotherapy’s most painful and persistent side effects. The research, published September 3 in the journal Science, examined whether psilocybin could prevent chemotherapy-induced peripheral neuropathy, commonly known ...
Elixinol Offloads Its US Hemp Business to Ananda Health
SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, Ananda Health will acquire the assets, intellectual property, and operational goodwill of Elixinol’s U.S. operations for a total headline consideration ...
ARPA-H Launches ASCENT-IBO Initiative for Ibogaine Clinical Research
WASHINGTON – The Advanced Research Projects Agency for Health (ARPA-H) has launched a federal research opportunity aimed at accelerating clinical evaluations of ibogaine for Opioid Use Disorder (OUD). Titled ASCENT-IBO, short for Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better Outcomes in Opioid Use Disorder, the program provides targeted federal backing for combined ...
cbdMD Moves to Acquire Twinlab
CHARLOTTE – cbdMD, Inc. entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife and Alvita Tea. The transaction is structured through an assignment for the benefit of creditors proceeding and remains subject to court approval along with customary closing conditions. Based on unaudited figures, ...
Trump Signs Hemp THC Ban Delay
WASHINGTON – President Donald Trump signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, pushing back sweeping federal restrictions on hemp-derived THC products from November 12 to December 11, 2026. Embedded in a must-pass government funding bill, the extension keeps full-spectrum CBD, low-dose THC beverages, gummies, and other popular hemp formulations on store shelves ...
Aurora vs Curaleaf: M&A Clash Reaches Shareholder Decision Point
EDMONTON - STAMFORD – Aurora Cannabis Inc. filed its directors' circular, unanimously urging shareholders to REJECT the unsolicited takeover bid from Curaleaf Holdings Inc., calling the offer inadequate and warning it puts long-term shareholder value at risk. Curaleaf fired back the same afternoon, reaffirming its bid and calling Aurora's board defiant at shareholders' expense. The ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Some weeks move the needle. The past fortnight moved the whole dial. A Phase 3 breakthrough, a nine-figure pharma bet, a federal price tag on legalization, hemp THC ban delay, and a hostile takeover bid that turned into a very public argument about what this industry is actually worth. Cannabis and Psychedelics ...
ATB Cormark Conference: Cannabis Operators Focus on Debt and Cash Flow
NEW YORK – Senior executives from major MSOs, including Green Thumb Industries, Trulieve Cannabis, Verano Holdings, Curaleaf and Vireo Growth are scheduled to hold private meetings with institutional fund managers in Manhattan next week at the ATB Cormark Cannabis Institutional Investor Conference. Hosted by ATB Cormark Capital Markets, the event marks the primary life sciences ...
Cresco Labs Closes Pennsylvania Dispensary Deal
CHICAGO – Cresco Labs Inc. announced the closing of its acquisition of 100% of the outstanding equity interests in PharmaCann Penn, LLC for an aggregate consideration of $50 million. The deal covers nine operational retail medical Cannabis dispensaries in the Keystone State – the transaction immediately accretive to revenue, margins and cash flow. The integration ...
Grön Scatters Pearls Over Four States at Once
PORTLAND – Grön officially announced that its flagship Pearls line is now available in California, Colorado, Michigan, and Nevada – the company's largest simultaneous multi-state rollout to date. The expansion places Grön inside some of the most competitive Cannabis retail environments in the country, where brands fight for limited shelf space and hard-to-retain consumer attention. ...
Headset Settles Federal PPP Loan Claims
SEATTLE – Headset Inc. agreed to pay more than $1 million to settle claims that it improperly received a Small Business Administration Paycheck Protection Program loan in February 2021, according to an announcement from First Assistant U.S. Attorney Charles Neil Floyd of the Western District of Washington. The loan was later forgiven in August 2021. ...
Oregon Consolidates Psilocybin and Medical Cannabis Under One Regulator
PORTLAND – The Oregon Health Authority (OHA) officially completes its administrative consolidation of Oregon Psilocybin Services (OPS) and the Oregon Medical Marijuana Program (OMMP), giving rise to a unified oversight body formally called the Oregon Psilocybin and Medical Cannabis Section (PMCS). The newly combined body brings together two programs that, for years, operated on separate ...
